Biomomentum Inc. is a Canadian biotechnology and manufacturing company offering a comprehensive suite of mechanical testing solutions for biomaterials and tissues. Founded in 1999, the company specializes in GLP-compliant biomechanical testing services and the manufacturing of innovative testing devices. The flagship product, Mach-1™ multiple-axis mechanical tester, sets itself apart by being the only all-in-one device designed for various testing applications including compression, tension, shear, friction, torsion, and indentation mapping of cartilage, soft tissue, and biomaterials. Its proprietary Normal Indentation technique enables automatic 3D mapping of the shape and mechanical properties of samples with curved surfaces. Additionally, Biomomentum offers a full-service approach to biomechanical testing with a focus on reliable testing protocols and accurate data analysis reports in compliance with Good Laboratory Practice. The company's products and services have garnered recognition within university labs and educational institutions, positioning the Mach-1™ as an excellent educational tool for students. Biomomentum's industry presence is rooted in its commitment to effective standard operating procedures, customizable accessories, and dedication to meeting clients' specific study requirements within the fields of biotechnology and manufacturing. With a strong foundation in place, Biomomentum presents an intriguing investment opportunity for venture capitalists seeking to support innovative technologies and solutions within the biomedical research and materials testing sectors.
There is no investment information
No recent news or press coverage available for Biomomentum Inc..